9:00 Exploring Liposome-Delivered Auger Radioligand Therapy for Target-Agnostic Destruction of Infiltrating Glioblastoma Cells – A First-in-Class Radiopharmaceutical
Time: 9:00 am
day: Day Two
Details:
- Usage of PET/MRI to evaluate nanocarrier biodistribution and Vd/Vi (volume of distribution/volume of infusion) ratios in porcine models by convection-enhanced delivery
- Convection-enhanced delivery of nanocarrier-based Auger radioligand therapy in glioblastoma – presentation of promising pre-clinical data
- How can we incorporate CED therapies in the current treatment of glioblastomas – a neurosurgeon’s perspective
